Our Services

Identification and characterization of cancer-specific mutations.

Detection of large chromosomal rearrangements in cancer cells.

Conduction of comprehensive genomic profiling for personalized medicine.

Evaluation of expression levels of cancer-specific biomarkers.

Validation of potential therapeutic targets through protein analysis.

Conduction of multiplex assays for simultaneous detection of multiple biomarkers.

Profiling of the immune cell populations in the tumor microenvironment.

Assessment of T-cell receptor diversity and clonality.

Evaluation of the functional activity of immune cells, such as cytotoxicity and cytokine production.

Assessment of cell proliferation rates.

Evaluation of apoptosis induction levels and measurement of cellular viability.

Monitoring the metabolic activity as an indicator of cell health.

Evaluation of the invasive potential of cancer cells.

Assessment of the effects of drugs on cell migration and invasion.

High-throughput screening for potential anticancer compounds for cytotoxicity.

Assessment of cell proliferation rates in response to treatments.

Identification of lead compounds and validation through secondary assays and mechanistic studies.